Technologically advanced cancer modeling in mice

Current Opinion in Genetics and Development

Volumn 12, Issue 1, 2002, Pages 105-110

  Tuveson, David A ^a,b   Jacks, Tyler ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; ALLELE; CANCER MODEL; CARCINOGENESIS; GENE TARGETING; GENETIC ENGINEERING; IN VIVO STUDY; MICROENVIRONMENT; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RODENT;

ANIMALIA; MURINAE; RODENTIA;

EID: 0036467484     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(01)00272-6     Document Type: Review

References (53)

1. Insights into cancer from transgenic mouse models
2. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis
3. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
4. Conditional gene knockout using Cre recombinase
5. The Flp recombinase of the 2-microns plasmid of Saccharomyces cerevisiae
6. High-efficiency deleter mice show that Flpe is an alternative to Cre-loxP
7. Site- and time-specific gene targeting in the mouse
8. Flp-mediated tissue specific inactivation of the retinoblastoma tumor suppressor gene in the mouse
9. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum
10. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2
11. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation
12. Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice
13. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain
14. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene
15. Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase
16. Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids
17. Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity
18. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells
19. Targeted oncogene activation by site-specific recombination in transgenic mice
20. Mouse model for lung tumorigenesis through Cre/Iox controlled sporadic activation of the K-ras oncogene
21. Cre-mediated chromosome loss in mice
22. Analysis of lung tumor initiation and progression using condtional expression of oncogenic K-ras
23. Generalized lacZ expression with the ROSA26 Cre reporter strain
24. Activation of EGFP expression by Cre-mediated excision in a new ROSA26 reporter mouse strain
25. A Flp indicator mouse expressing alkaline phosphatase from the ROSA26 locus
26. Long-term, noninvasive imaging of regulated gene expression in living mice
27. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
28. Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells
29. Tet repressor-based system for regulated gene expression in eukaryotic cells: Principles and advances
30. Essential role for oncogenic Ras in tumour maintenance
31. Reversible tumorigenesis by Myc in hematopoietic lineages
32. Reversibility of acute B-cell leukaemia induced by BCR-ABL1
33. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes
34. Reversible activation of c-Myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion
35. Development of a flexible and specific gene delivery system for production of murine tumor models
36. Combined activation of Ras and AKT in neural progenitors induces glioblastoma formation in mice
37. Induction of ovarian cancer by defined multiple genetic changes in a mouse model system
38. Development of an avian leukosis-sarcoma virus subgroup A pseudotyped lentiviral vector
39. Longevity, stress response, and cancer in aging telomerase-deficient mice
40. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
41. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis
42. Short dysfunctional telomeres impair tumorigenesis in the INK4a (delta2/3) cancer-prone mouse
43. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans
44. Cancer predisposition caused by elevated mitotic recombination in bloom mice
45. Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine bloom's syndrome gene
46. Mutation in the mismatch repair gene Msh6 causes cancer susceptibility
47. Tumorigenesis in Mlh1 and Mlh1/Apc 1638N mutant mice
48. Tumor-associated Apc mutations in Mlh1-/- Apc1638N mice reveal a mutational signature of Mlh1 deficiency
49. Min/+ mice
50. Genomic instability-based transgenic models of prostate cancer
51. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects
52. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors
53. The mammary pathology of genetically engineered mice: The consensus report and recommendations from the Annapolis meeting